Hawaii HR 166: URGING THE GOVERNOR, DEPARTMENT OF HUMAN SERVICES, AND DEPARTMENT OF HEALTH TO EXPLORE AVENUES TO ENSURE CONTINUED ACCESS TO AFFORDABLE MEDICATIONS FOR THE STATE'S UNDERSERVED POPULATIONS UNDER THE 340B DRUG PRICING PROGRAM AND URGING HAWAII'S CONGRESSIONAL DELEGATION AND RELEVANT FEDERAL AGENCIES TO MONITOR PHARMACEUTICAL COMPANIES AND TAKE APPROPRIATE ACTIONS TO PROTECT THE INTEGRITY OF THE 340B DRUG PRICING PROGRAM.

Status: Reported from FIN (Stand. Com. Rep. No. 1641-24), recommending adoption. (as of 2024-04-04)

State: Hawaii · Session: 2024 · Bill: HR 166

Subjects: 340B Drug Pricing Program, Access to Affordable Pharmaceuticals, DHS, DOH, Governor, Hawaiʻi Congressional Delegation, Health Resources and Services Administration

Sponsors: AMATO, BELATTI, MARTEN, NISHIMOTO, TAKENOUCHI

View Hawaii HR 166 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.